Literature DB >> 29031067

New pyridine derivatives as inhibitors of acetylcholinesterase and amyloid aggregation.

Fabiana Pandolfi1, Daniela De Vita1, Martina Bortolami1, Antonio Coluccia1, Roberto Di Santo2, Roberta Costi2, Vincenza Andrisano3, Francesco Alabiso4, Christian Bergamini4, Romana Fato4, Manuela Bartolini5, Luigi Scipione6.   

Abstract

A new series of pyridine derivatives with carbamic or amidic function has been designed and synthesized to act as cholinesterase inhibitors. The synthesized compounds were tested toward EeAChE and hAChE and toward eqBChE and hBChE. The carbamate 8 was the most potent hAChE inhibitor (IC50 = 0.153 ± 0.016 μM) while the carbamate 11 was the most potent inhibitor of hBChE (IC50 = 0.828 ± 0.067 μM). A molecular docking study indicated that the carbamate 8 was able to bind AChE by interacting with both CAS and PAS, in agreement with the mixed inhibition mechanism. Furthermore, the carbamates 8, 9 and 11 were able to inhibit Aβ42 self-aggregation and possessed quite low toxicity against human astrocytoma T67 and HeLa cell lines, being the carbamate 8 the less toxic compound on both cell lines.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Acetylcholinesterase inhibitors; Amyloid aggregation inhibitors; Butyrylcholinesterase inhibitors

Mesh:

Substances:

Year:  2017        PMID: 29031067     DOI: 10.1016/j.ejmech.2017.09.022

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  7 in total

1.  Cysteine-Targeted Insecticides against A. gambiae Acetylcholinesterase Are Neither Selective nor Reversible Inhibitors.

Authors:  Lukas Gorecki; Rudolf Andrys; Monika Schmidt; Tomas Kucera; Miroslav Psotka; Barbora Svobodova; Veronika Hrabcova; Vendula Hepnarova; Petr Bzonek; Daniel Jun; Kamil Kuca; Jan Korabecny; Kamil Musilek
Journal:  ACS Med Chem Lett       Date:  2019-11-26       Impact factor: 4.345

Review 2.  Inhibitory potential of nitrogen, oxygen and sulfur containing heterocyclic scaffolds against acetylcholinesterase and butyrylcholinesterase.

Authors:  Rami J Obaid; Nafeesa Naeem; Ehsan Ullah Mughal; Munirah M Al-Rooqi; Amina Sadiq; Rabab S Jassas; Ziad Moussa; Saleh A Ahmed
Journal:  RSC Adv       Date:  2022-07-12       Impact factor: 4.036

3.  Design, Synthesis, and In Vitro, In Silico and In Cellulo Evaluation of New Pyrimidine and Pyridine Amide and Carbamate Derivatives as Multi-Functional Cholinesterase Inhibitors.

Authors:  Martina Bortolami; Fabiana Pandolfi; Valeria Tudino; Antonella Messore; Valentina Noemi Madia; Daniela De Vita; Roberto Di Santo; Roberta Costi; Isabella Romeo; Stefano Alcaro; Marisa Colone; Annarita Stringaro; Alba Espargaró; Raimon Sabatè; Luigi Scipione
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-27

4.  The Antiviral Drug Tilorone Is a Potent and Selective Inhibitor of Acetylcholinesterase.

Authors:  Patricia A Vignaux; Eni Minerali; Thomas R Lane; Daniel H Foil; Peter B Madrid; Ana C Puhl; Sean Ekins
Journal:  Chem Res Toxicol       Date:  2021-01-05       Impact factor: 3.739

5.  Correction to: New cyclopentaquinoline hybrids with multifunctional capacities for the treatment of Alzheimer's disease.

Authors: 
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

6.  Crystal structure and Hirshfeld surface analysis of 4-(3-meth-oxy-phen-yl)-2,6-di-phenyl-pyridine.

Authors:  Dong Cheng; Xiang-Zhen Meng; Fuyu Tian; Dong Yan; Xiaofei Wang; Xueli Qian; Junnan Wang
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2022-08-23

Review 7.  New and Developing Therapies in Spinal Muscular Atrophy: From Genotype to Phenotype to Treatment and Where Do We Stand?

Authors:  Tai-Heng Chen
Journal:  Int J Mol Sci       Date:  2020-05-07       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.